Glaxosmithkline Plc Morphic Holding, Inc. (MORF) insider trading activity

MORF Quotes by TradingView

GLAXOSMITHKLINE PLC Transaction History

Date Transaction Value Shares Traded Form
Jul 01 2019
BUY
Open market or private purchase
$4,999,995 $15.0 p/Share
333,333
Jul 01 2019
BUY
Conversion of derivative security
-
2,300,439

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
> 10% Shareholder
SPRO
Spero Therapeutics, Inc. Healthcare
> 10% Shareholder
TBIO
Translate Bio, Inc. Healthcare
> 10% Shareholder
LQDA
Liquidia Technologies Inc
PRNB
Principia Biopharma Inc.
CCXI
ChemoCentryx, Inc.
TPTX
Turning Point Therapeutics, Inc.
Director
BCYC
BICYCLE THERAPEUTICS plc Healthcare
> 10% Shareholder
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
> 10% Shareholder
FULC
Fulcrum Therapeutics, Inc. Healthcare
PGNY
Progyny, Inc. Healthcare
> 10% Shareholder
NKTX
Nkarta, Inc. Healthcare
Director
PAND
Pandion Therapeutics, Inc.
Director
DBTX
Decibel Therapeutics, Inc. Healthcare
Director
INVA
Innoviva, Inc. Healthcare
> 10% Shareholder
LYEL
Lyell Immunopharma, Inc. Healthcare
> 10% Shareholder
CVRX
CVRx, Inc. Healthcare
> 10% Shareholder
TBPH
Theravance Biopharma, Inc. Healthcare
WVE
Wave Life Sciences Ltd. Healthcare
> 10% Shareholder
GP

Glaxosmithkline PLC

Director
Brentford Middlesex, X0

Track Institutional and Insider Activities on MORF

Follow Morphic Holding, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MORF shares.

Notify only if

Insider Trading

Get notified when an Morphic Holding, Inc. insider buys or sells MORF shares.

Notify only if

News

Receive news related to Morphic Holding, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MORF